Related Experiment Video
Updated: Aug 8, 2025

05:19
Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
Published on: March 29, 2019
10.4K
miRNAs and arsenic-induced carcinogenesis
Alexandra N Nail1, Ana P Ferragut Cardoso1, Lakyn K Montero1
1Department of Pharmacology and Toxicology, Center for Integrative Environmental Health Science, University of Louisville, Louisville, KY, United States.
Advances in Pharmacology (San Diego, Calif.)
|March 1, 2023
Summary
Arsenic exposure causes cancer worldwide. This review details how microRNA (miRNA) changes contribute to arsenic-induced cancers, aiding in developing new treatments.
Area of Science:
- Environmental Health Sciences
- Molecular Biology
- Cancer Research
Background:
- Arsenic-induced carcinogenesis is a significant global health concern.
- Understanding the molecular drivers of arsenic-related cancers is crucial for effective treatment strategies.
- MicroRNA (miRNA) dysregulation is increasingly recognized as a key factor in cancer development and progression.
Approach:
- This chapter comprehensively reviews the current literature on miRNA dysregulation in arsenic-induced cancers.
- It examines studies linking altered miRNA expression in individuals with chronic arsenic exposure to cancer development.
- The review also includes findings from cell models investigating arsenic-induced carcinogenesis.
Key Points:
- Altered miRNA expression is consistently observed in cancers associated with chronic arsenic exposure.
- miRNA dysregulation plays a role in the molecular mechanisms underlying arsenic-induced carcinogenesis.
- Specific miRNAs may serve as biomarkers or therapeutic targets for arsenic-related cancers.
Conclusions:
- miRNA dysregulation is a critical component of arsenic-induced carcinogenesis.
- Further research into miRNA's role can lead to novel diagnostic and therapeutic approaches for arsenic-related cancers.
- Addressing miRNA alterations presents a promising avenue for combating arsenic-induced cancer globally.
Related Concept Videos
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Induced Pluripotent Stem Cells
4.2K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.2K
Spontaneous and Induced Mutations
79
Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
79

